A recent study suggests that individuals who discontinue blockbuster slimming jabs like Wegovy and Mounjaro can put back on lost weight at a significantly accelerated pace than those who end traditional diet and exercise plans.
Research printed in a leading health publication demonstrates that while obese individuals can lose substantial amounts of their body weight while using the jabs, the weight comes back at an average rate of nearly a kilo each month upon discontinuation.
"People purchasing these medications must be cognizant of the danger of fast rebound weight gain when the therapy ends," stated researcher Dr. Susan Jebb.
This pace of regain implies a return to pre-treatment weight within about 18 months.
Analyzing Approaches
The study, which examined dozens of studies involving over 9,000 of patients, contrasted the effects of GLP-1 agonists with conventional dieting.
Researchers note that individuals who lose weight through diet and exercise usually see a slower weight regain—perhaps 0.1 kg a month—once they finish.
The Reason for the Fast Rebound
Experts believe the mode of action of the injections explains the amplified rebound.
GLP-1 drugs copy a natural hormone called GLP-1, which helps regulate appetite.
"Artificially providing GLP-1 concentrations several times higher than normal could lead to the body to generate a reduced amount of its endogenous hormone, and may also lessen sensitivity to its actions," said Dr. Adam Collins, a nutrition researcher.
"Withdrawal of this hormone supplement results in appetite is uncontrolled, making binge eating much more probable."
An Ongoing Condition?
Medical guidelines recommend the injections for individuals with obesity-related health risks, accompanied by prescribed lifestyle changes.
A number of clinicians say that, considering the significant potential of weight regain, the therapy is often long-term.
This perspective is echoed by drug manufacturers, who state that the findings "highlight the long-term character of obesity," akin to managing conditions like hypertension.
User Testimonies
Individuals who have come off the medication report a sudden resurgence of hunger.
"It was like a switch activating and you become starving," described an individual.
This challenge is compounded if individuals have not developed lasting dietary or behavioural changes during treatment.
Widespread Adoption
Figures suggest that millions of people in the UK have tried weight-loss jabs in the last 12 months, with interest remaining high.
- Use is greater among females compared to males.
- The middle-aged demographic shows the highest usage rates.
- A large proportion obtain the drugs through private prescriptions rather than the NHS.
In conclusion, researchers emphasize that while the jabs are powerful agents for weight loss, they are not a magic cure and long-term success relies on ongoing lifestyle management.
